Chargement en cours...
Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
BACKGROUND: The aim was to evaluate factor XIII activity (FXIIIa) and monocyte-derived microparticles (MDMPs) in cancer patients. METHODS: In total, 138 cancer patients (31 malignant lymphomas, 39 multiple myelomas, and 68 lung cancers) were analyzed. We measured various biomarkers including FXIIIa...
Enregistré dans:
| Publié dans: | Vasc Health Risk Manag |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7131992/ https://ncbi.nlm.nih.gov/pubmed/32280233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S240500 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|